{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:17:44Z","timestamp":1793643464407,"version":"4.5.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"National League Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.immuni.2026.05.018","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:39:04Z","timestamp":1782311944000},"page":"1876-1893.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The transcription factor Eomes drives a stemness program in CD4+ T cells that promotes anti-tumor immunity in response to immunotherapy"],"prefix":"10.1016","volume":"59","author":[{"given":"Arantxa","family":"Agesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Louise","family":"Le Dorze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Peillex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Barascud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Palak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanguy","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Joulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Colacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Margarido","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Peroceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Chaubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Zahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhadi","family":"Saoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"El Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Adoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana E.","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Martinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-1113","authenticated-orcid":false,"given":"Anne S.","family":"Dejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.05.018_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.018_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T cells: key to successful immunotherapy?","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coviro.2016.01.002","article-title":"Immune-surveillance through exhausted effector T-cells","volume":"16","author":"Zehn","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.immuni.2026.05.018_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib9","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1084\/jem.20121015","article-title":"Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice","volume":"209","author":"Frebel","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.018_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.018_bib16","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.05.018_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.018_bib24","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib25","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI98689","article-title":"Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma","volume":"128","author":"Veatch","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.immuni.2026.05.018_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","article-title":"Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors","volume":"42","author":"Espinosa-Carrasco","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib20","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"Perez-Diez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2026.05.018_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20091921","article-title":"Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma","volume":"207","author":"Xie","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113797","article-title":"Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment","volume":"43","author":"Zhou","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.018_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccell.2022.03.006","article-title":"Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function","volume":"40","author":"Veatch","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.immuni.2022.05.003","article-title":"BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen","volume":"55","author":"Xia","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1126\/science.1259357","article-title":"Time-resolved serial crystallography captures high-resolution intermediates of photoactive yellow protein","volume":"346","author":"Tenboer","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.018_bib30","first-page":"4234","article-title":"CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade","volume":"10","author":"Fu","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib31","doi-asserted-by":"crossref","first-page":"21182","DOI":"10.1073\/pnas.1118450109","article-title":"Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection","volume":"108","author":"Aubert","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.018_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108748","article-title":"Dynamic adoption of anergy by antigen-exhausted CD4+ T cells","volume":"34","author":"Trefzer","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.018_bib33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1084\/jem.20151995","article-title":"Blimp-1\u2013mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis","volume":"213","author":"Hwang","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.1090148","article-title":"Control of effector CD8+ T cell function by the transcription factor Eomesodermin","volume":"302","author":"Pearce","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.018_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20081242","article-title":"Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs","volume":"206","author":"Cruz-Guilloty","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib36","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1002042","article-title":"Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche","volume":"185","author":"Banerjee","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib38","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.018_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/eji.201848000","article-title":"The role of Eomes in human CD4 T cell differentiation: A question of context","volume":"49","author":"Dejean","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.immuni.2016.09.010","article-title":"Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes","volume":"45","author":"Stienne","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib41","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230449","article-title":"Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation","volume":"221","author":"Joulia","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9437","article-title":"Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation","volume":"6","author":"Raveney","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.018_bib43","doi-asserted-by":"crossref","first-page":"21131","DOI":"10.1073\/pnas.1906438116","article-title":"Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.018_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/eji.201747296","article-title":"EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers","volume":"48","author":"Chemin","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin Promotes the Development of Type-1 Regulatory T","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib46","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41375-021-01136-1","article-title":"EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia","volume":"35","author":"Roessner","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.immuni.2026.05.018_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-10-146","article-title":"Biomarkers on melanoma patient T Cells associated with ipilimumab treatment","volume":"10","author":"Wang","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Buggert","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2026.05.018_bib49","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-18-3107","article-title":"Eomes+T-betlow CD8+ T cells are functionally impaired and are associated with poor clinical outcome in patients with acute myeloid leukemia","volume":"79","author":"Jia","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib50","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41590-021-01060-7","article-title":"Dynamic CD4+ T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection","volume":"22","author":"Snell","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.20121190","article-title":"Systemic 4\u20131BB activation induces a novel T cell phenotype driven by high expression of eomesodermin","volume":"210","author":"Curran","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.immuni.2020.09.006","article-title":"Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy","volume":"53","author":"Weulersse","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.immuni.2023.06.007","article-title":"TCR-independent CD137 (4\u20131BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation","volume":"56","author":"Pichler","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4\u20131BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib56","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI77181","article-title":"Immunosurveillance and therapy of multiple myeloma are CD226 dependent","volume":"125","author":"Guillerey","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.immuni.2026.05.018_bib57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib58","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T cells establish and propagate T cell exhaustion in chronic infection","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","article-title":"MYB orchestrates T cell exhaustion and response to checkpoint inhibition","volume":"609","author":"Tsui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.018_bib60","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41590-019-0403-4","article-title":"Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection","volume":"20","author":"Yao","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2019.04.014","article-title":"Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections","volume":"58","author":"Philip","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2019.08.013","article-title":"The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8+ T cell fitness and functionality","volume":"51","author":"Li","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade3369","article-title":"In vitro modeling of CD8+ T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40","volume":"8","author":"Wu","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41590-024-02023-4","article-title":"Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma","volume":"26","author":"Lu","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib65","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200921","article-title":"Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells","volume":"218","author":"Lucca","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.018_bib67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.018_bib68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-019-0357-y","article-title":"A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma","volume":"25","author":"Huang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib69","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02981","article-title":"High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/eji.201847677","article-title":"Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation","volume":"49","author":"Mazzoni","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/eji.201847722","article-title":"Eomesodermin controls a unique differentiation program in human IL-10 and IFN-\u03b3 coproducing regulatory T cells","volume":"49","author":"Gruarin","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07975-2","article-title":"Signs of innate immune activation and premature immunosenescence in psoriasis patients","volume":"7","author":"\u0160ahmatova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2026.05.018_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00372","article-title":"Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients","volume":"11","author":"Pirozyan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib80","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","article-title":"Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade","volume":"170","author":"Wei","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76339","article-title":"A CD4+ T cell reference map delineates subtype-specific adaptation during acute and chronic viral infections","volume":"11","author":"Andreatta","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.05.018_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1 \u2212 CD8 + Tumor-Infiltrating T Cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib83","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","article-title":"CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer","volume":"51","author":"Zander","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib84","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","article-title":"Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection","volume":"51","author":"Hudson","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib95","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41590-022-01338-4","article-title":"Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics","volume":"23","author":"Giles","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.coi.2007.01.003","article-title":"Terminal differentiation of lymphocytes depends on Blimp-1","volume":"19","author":"Kallies","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib86","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2009.05.014","article-title":"Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties","volume":"31","author":"Rutishauser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.018_bib87","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20142237","article-title":"Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells","volume":"212","author":"Odorizzi","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib88","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.018_bib89","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.018_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113898","article-title":"NR4a1\/2 deletion promotes accumulation of TCF1+ stem-like precursors of exhausted CD8+ T cells in the tumor microenvironment","volume":"43","author":"Srirat","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.018_bib91","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20170155","article-title":"The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination","volume":"215","author":"Yu","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.018_bib92","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/2326-6066.CIR-21-0129","article-title":"BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy","volume":"10","author":"Salmon","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib93","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.4049\/jimmunol.0904089","article-title":"Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells","volume":"184","author":"Mitchell","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib94","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/2326-6066.CIR-23-1001","article-title":"Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy","volume":"12","author":"Teo","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib96","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T cells: key to successful immunotherapy?","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib97","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.1000749","article-title":"T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses","volume":"185","author":"Zhu","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.018_bib98","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.05.018_bib99","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/dvg.22052","article-title":"Generation of CD4CreERT2 transgenic mice to study development of peripheral CD4-T-cells","volume":"50","author":"Aghajani","year":"2012","journal-title":"Genesis"},{"key":"10.1016\/j.immuni.2026.05.018_bib100","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","article-title":"Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib102","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib103","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-13-1646","article-title":"Combined anti-cd40 and anti-il-23 monoclonal antibody therapy effectively suppresses tumor growth and metastases","volume":"74","author":"Von Scheidt","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib104","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1073\/pnas.0801506105","article-title":"Differentiation of regulatory Foxp3+ T cells in the thymic cortex","volume":"105","author":"Liston","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"43","key":"10.1016\/j.immuni.2026.05.018_bib120","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Journal of Open Source Software"},{"key":"10.1016\/j.immuni.2026.05.018_bib105","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.immuni.2026.05.018_bib106","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"Street","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.immuni.2026.05.018_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.05.018_bib108","doi-asserted-by":"crossref","first-page":"D933","DOI":"10.1093\/nar\/gkac958","article-title":"Ensembl 2023","volume":"51","author":"Martin","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.05.018_bib109","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.05.018_bib110","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Cambridge (Mass.))"},{"key":"10.1016\/j.immuni.2026.05.018_bib111","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.immuni.2026.05.018_bib112","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.05.018_bib113","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Di Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.05.018_bib114","doi-asserted-by":"crossref","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"10.1016\/j.immuni.2026.05.018_bib115","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ccell.2024.08.007","article-title":"Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.018_bib116","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.05.018_bib117","unstructured":"Wang, J., and Liao, Y. (2023). Gene Set Analysis Toolkit WebGestaltR [R package WebGestaltR version 0.4.6]. 10.32614\/CRAN.PACKAGE.WEBGESTALTR."},{"key":"10.1016\/j.immuni.2026.05.018_bib118","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.05.018_bib119","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203828120","article-title":"Sccomp: Robust differential composition and variability analysis for single-cell data","volume":"120","author":"Mangiola","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:29:38Z","timestamp":1793107778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326002293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":114,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1074761326002293"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.018","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transcription factor Eomes drives a stemness program in CD4+ T cells that promotes anti-tumor immunity in response to immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}